Eva Stroynowski

Eva Stroynowski joined Omega’s leadership team with nearly 20 years of investor relations and corporate affairs experience within the biopharmaceutical industry. Prior to Omega, Ms. Stroynowski served as Vice President of Communications and Investor Relations at Olema Oncology. Previously, she spent 14 years at Alkermes plc in roles of increasing responsibility spanning investor relations and corporate communications. As the Vice President of Corporate Affairs at Alkermes, she led the company’s global communications efforts with responsibility for corporate brand and reputation, commercial product and R&D communications, employee communications, patient engagement, corporate social responsibility, and corporate events.

Earlier in her career, Ms. Stroynowski worked in public health communications as part of The Medical Foundation in Boston. She previously spent several years conducting clinical research at Harvard Medical School in the Division of Sleep Medicine.

Ms. Stroynowski earned a B.S. in Psychology from Carnegie Mellon University and an MPH from Tufts University School of Medicine.